An ABC of Drug-Related Problems
- 1 January 2000
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 22 (6) , 415-423
- https://doi.org/10.2165/00002018-200022060-00001
Abstract
The problems relating to the use of medicines are manifold. They may differ in pharmacological, pathological, epidemiological and legal respects, and may have different consequences, for example, as regards scientific study, regulation or rational use. Pharmacovigilance is concerned with all such problems: adverse effects and interactions as well as problems relating to ineffectiveness, inappropriate use, counterfeiting, dependence or poisoning. Practically all medicine-related problems can be classified in one basic system, taking into account their characteristics and distinctions. This system distinguishes between appropriate and inappropriate drug use, dose-related and dose-unrelated problems, and types A (‘drug actions’), B (‘patient reactions’) and C (‘statistical’) adverse effects. This classification may serve as an educational tool and may be useful in when choosing a study method and for the design of effective strategies in pharmacovigilance.Keywords
This publication has 14 references indexed in Scilit:
- Survey of unlicensed and off label drug use in paediatric wards in European countriesBMJ, 2000
- [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].1999
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- Analgesic NephropathyNew England Journal of Medicine, 1998
- Increase in US medication-error deaths between 1983 and 1993The Lancet, 1998
- Principles of Signal Detection in PharmacovigilanceDrug Safety, 1997
- The Antidepressant WebInternational Journal of Risk & Safety in Medicine, 1997
- Characteristics of Topics in Pharmacovigilance in The Netherlands†Clinical Drug Investigation, 1996
- Harmonisation in PharmacovigilanceDrug Safety, 1994
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978